Thomas Simmerer takes over sales at Carl Zeiss Meditec
Succeeds Ulrich Krauss as member of the management board with responsibility for sales
‘I am looking forward to my new responsibilities and will maintain and expand the successful sales and service structure at Carl Zeiss Meditec in the respective markets,’ said Simmerer.
Simmerer has extensive experience in medical technology. He was in charge of the Microsurgery strategic business unit in Oberkochen from October 2008. Before joining the medical wing of Carl Zeiss, the mechanical engineer led the top-performing business unit, among others, of Dräger Medical in Lübeck from 1996 to 2008. Prior to this, he was responsible for different sales areas at Heraeus in Hanau.
You may also like
Pharma 5.0
ZEISS and Concept Life Sciences partner to advance automated workflows and AI-powered image analysis in spatial biology
The collaboration focusses on high-throughput imaging, AI-driven data analysis and streamlined integration into lab systems, aiming to improve efficiency and data quality for areas such as drug discovery and cancer research
Research & Development
Medicines Discovery Catapult and ZEISS set sights on advancing microscopy in drug discovery
Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions
Marketing
Guardtech Group welcome new ‘cleanroom chameleon’ mascot into the mix to celebrate company’s role as enablers of change
Cammi the Chameleon will be appearing across the East Anglian cleanroom construction specialists’ marketing throughout 2026 to represent Guardtech’s aim to support groundbreaking developments in Life Sciences and beyond
Drug Delivery
SCHOTT Pharma and SHL Medical pre-validate polymer cartridge platform for large-volume autoinjectors
SCHOTT Pharma has pre-validated its ISO-standardised TOPPAC polymer cartridge for compatibility with SHL Medical’s large-volume Maggie autoinjector platform. The collaboration delivers a de-risked, ready-to-use solution for the safe at-home administration of large-volume therapies